Objective: To determine the diagnostic accuracy of an investigational test for human immunodeficiency virus (HIV) envelope antibodies in urine.
Design: Matched blood and urine specimens were tested for HIV by two independent laboratories, both of which were blinded to all results at the other site. Duplicate positive enzyme-linked immunoassay (EIA) results were confirmed by immunofluorescent antibody or western blot.
Setting: Six alcohol treatment centers in the San Francisco metropolitan area.
Patients: Five hundred ninety-two recovering alcoholics.
Main Outcome Measures: Diagnosis of HIV infection by blood and urine EIA and western blot.
Results: The experimental urine EIA, when confirmed by urine western blot, led to a correct diagnosis in all samples. One sample was negative by urine EIA screening, positive by blood EIA, and exhibited an indeterminate blood western blot pattern (p24 band only).
Conclusions: We encountered no false positive or false negative results using an investigational HIV antibody test for urine samples. There are several important advantages to HIV testing of urine versus serum or blood; however, there are also cogent reasons for limiting the use of alternative specimens for HIV testing.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Evaluation of a commercial Histoplasma antigen detection enzyme immunoassay for the follow-up of histoplasmosis treatment in people living with HIV from Argentina.
Med Mycol
December 2024
Unidad Micología, Hospital de Enfermedades Infecciosas Dr. Francisco J. Muñiz, CABA, Argentina.
Article Synopsis
- Histoplasmosis is particularly dangerous for HIV patients, especially where antiretroviral therapy is hard to get, making antigen detection assays vital for quick diagnoses and reducing mortality.
- The study assessed 27 HIV patients with histoplasmosis over 24 weeks, monitoring urinary Histoplasma antigen levels as they received treatment with amphotericin B followed by itraconazole.
- Results indicated that as antigen levels decreased, patient clinical outcomes improved, suggesting that the clarus Histoplasma GM EIA kit could effectively monitor treatment responses, despite some patients having atypical antigen patterns due to immune system responses or medication absorption issues.
Implementation of Antigen-Based Diagnostic Assays for Detection of Histoplasmosis and Cryptococcosis among Patients with Advanced HIV in Trinidad and Tobago: A Cross-Sectional Study.
J Fungi (Basel)
October 2024
Department of Communicable Diseases Prevention, Control, and Elimination, Pan American Health Organization, Washington, DC 20037, USA.
The Caribbean continues to have high HIV prevalence globally with concurrently high mortality rates due to opportunistic Infections. This study addresses the prevalence of histoplasmosis and cryptococcosis among patients living with advanced HIV disease (AHD) in Trinidad and Tobago, focusing on the implementation of antigen-based diagnostic assays. Conducted as a cross-sectional survey across five HIV treatment sites, 199 participants with advanced HIV disease were enrolled between July 2022 and September 2023.
View Article and Find Full Text PDFTesting for Blastomycosis, Coccidioidomycosis, and Histoplasmosis at a Major Commercial Laboratory, United States, 2019-2024.
Open Forum Infect Dis
August 2024
Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Article Synopsis
- Blastomycosis, coccidioidomycosis, and histoplasmosis are fungal diseases that mimic pneumonia symptoms, causing diagnostic delays as healthcare providers often don’t consider them initially.
- A study analyzed lab tests from a national lab system between 2019 and 2024, revealing low positive rates for these diseases and highlighting that most tests were ordered by hospitals for histoplasmosis and blastomycosis, while primary care providers primarily ordered coccidioidomycosis tests.
- The findings suggest these fungal infections may be underdiagnosed in primary care and public health settings, signaling a need for greater testing and enhanced surveillance to better manage these diseases.
Histoplasmosis in domestic cats: new minimally invasive diagnostic techniques.
J Feline Med Surg
June 2024
Department of Veterinary Medicine and Surgery, Veterinary Institute, Federal Rural University of Rio de Janeiro (UFRRJ), Seropédica, Brazil.
Objectives: The aim of the present study was to evaluate minimally invasive diagnostic techniques, such as the semi-quantitative indirect IgG antibody enzyme immunoassay (EIA) using blood serum and the urinary lateral flow assay (LFA), for the detection of in cats with histoplasmosis.
Methods: Eight client-owned domestic cats diagnosed with histoplasmosis were selected based on cytological, histopathological, mycological, molecular or antigenic techniques. The blood serum of these animals was tested in a semi-quantitative indirect IgG antibody EIA for the detection of .
A commercial whole blood polymerase chain reaction assay failed to diagnose histoplasmosis in cats confirmed by cytology or urine antigen detection.
J Am Vet Med Assoc
September 2024
2MiraVista Diagnostics, Indianapolis, IN.
Objective: To determine the sensitivity and specificity of a commercial whole blood real-time PCR assay (RT-PCR) for the diagnosis of histoplasmosis when compared to direct organism identification and/or urine antigen quantification by enzyme immunoassay (UA-EIA). A secondary objective was to compare the sensitivity and specificity of RT-PCR to anti-Histoplasma immunoglobulin G antibody detection by enzyme immunoassay (IgG-EIA) and IgG-EIA to UA-EIA.
Animals: Cats presented to the Kansas State University Veterinary Health Center from February through September of 2023 in which histoplasmosis was diagnosed or suspected.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!